Skip to main content

Neuroimaging in bulimia nervosa and binge eating disorder: a systematic review



In recent decades there has been growing interest in the use of neuroimaging techniques to explore the structural and functional brain changes that take place in those with eating disorders. However, to date, the majority of research has focused on patients with anorexia nervosa. This systematic review addresses a gap in the literature by providing an examination of the published literature on the neurobiology of individuals who binge eat; specifically, individuals with bulimia nervosa (BN) and binge eating disorder (BED).


A systematic review was conducted in accordance with PRISMA guidelines using PubMed, PsycInfo, Medline and Web of Science, and additional hand searches through reference lists. 1,003 papers were identified in the database search. Published studies were included if they were an original research paper written in English; studied humans only; used samples of participants with a diagnosed eating disorder characterised by recurrent binge eating; included a healthy control sample; and reported group comparisons between clinical groups and healthy control groups.


Thirty-two papers were included in the systematic review. Significant heterogeneity in the methods used in the included papers coupled with small sample sizes impeded the interpretation of results. Twenty-one papers utilised functional Magnetic Resonance Imaging (fMRI); seven papers utilized Magnetic Resonance Imaging (MRI) with one of these using both MRI and Positron Emission Technology (PET); three studies used Single-Photon Emission Computed Tomography (SPECT) and one study used PET only. A small number of consistent findings emerged in individuals in the acute phase of illness with BN or BED including: volume reduction and increases across a range of areas; hypoactivity in the frontostriatal circuits; and aberrant responses in the insula, amygdala, middle frontal gyrus and occipital cortex to a range of different stimuli or tasks; a link between illness severity in BN and neural changes; diminished attentional capacity and early learning; and in SPECT studies, increased rCBF in relation to disorder-related stimuli.


Studies included in this review are heterogenous, preventing many robust conclusions from being drawn. The precise neurobiology of BN and BED remains unclear and ongoing, large-scale investigations are required. One clear finding is that illness severity, exclusively defined as the frequency of binge eating or bulimic episodes, is related to greater neural changes. The results of this review indicate additional research is required, particularly extending findings of reduced cortical volumes and diminished activity in regions associated with self-regulation (frontostriatal circuits) and further exploring responses to disorder-related stimuli in people with BN and BED.

Plain English summary

This paper is a systematic review of research investigating structural and functional differences transdiagnostically; that is, in people who have an eating disorder characterized by binge eating, either Bulimia Nervosa (BN) or Binge Eating Disorder (BED), when compared to healthy people with no eating disorder or other mental illness. Using a set of fixed search terms, we completed a systematic review of published peer-reviewed scientific papers, identifying thirty-two papers that met the inclusion criteria. The majority of papers reviewed used functional Magnetic Resonance Imaging (fMRI) and the rest used one or two other neuroimaging tests. An overview and synthesis of the results of the papers is provided, grouped according to the type of test completed. A small number of findings emerged of individuals with BN or BED when they have clinically significant symptoms, highlighting there are reductions in the overall size of the brain in BN and BED and diminished activity in regions associated with self regulation (frontostriatal circuits). Also, some studies highlight differences in the activity within neural regions associated with emotional processing (amygdala), attention and spatial manipulation (middle frontal gyrus) and visual processing (occipital cortex). We discuss the implications of the results and highlight recommendations for future neurobiological research based on our findings.


Recurrent binge eating is a debilitating symptom that is a core diagnostic criterion for bulimia nervosa (BN) and binge eating disorder (BED); it also occurs in anorexia nervosa-binge purge type (AN-BP), and is a common feature in other specified feeding and eating disorder (OSFED). The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [1] specifies that individuals are engaging in objective binge episodes (OBEs) at least once per week to reach a diagnosis of BN or BED. This differs from the proposed ICD-11 criterion where the binge episode (BE) is not required to be objectively large and can look like subjective binge episodes (SBEs) [2]. BN involves binge episodes (BEs)Footnote 1 followed by inappropriate compensatory behaviours to avoid weight gain, such as purging, while BED involves engaging in recurrent binge episodes with no compensatory strategies [1].

BN and BED are disorders with noted social and health consequences that typically arise in later adolescent and young adult years [3]. In a cross-sectional population survey of Australian adults, the three-month prevalence of BN and BED ranged from 1.1-1.5% [4]. In 2014 in the Australian population, the prevalence of recurrent binge eating with or without distress was 10.1% and 13.0% in 2015 [3]. Psychiatric comorbidity, particularly with depression and anxiety disorders, is common [5, 7] and mortality is increased [6]. Over one in five individuals with BN will attempt suicide during their life, with factors relating to emotion dysregulation, lifetime anxiety and depression [7].

Treatments and assessments for BN and BED have been developed based on the current definition of BEs. Cognitive Behavioural Therapy (CBT) is the first-line treatment for BN and BED [8]. Available psychological treatments are moderately effective and medication may offer benefits but longer-term maintenance of effects are unclear [9,10,11,12]. Research has demonstrated that the majority of individuals with BN and BED do not seek treatment for their eating disorder, but instead present for weight loss treatment [13, 14].

In recent decades, major advances have taken place in the field of neuroscience, which has increased knowledge of the interrelationship between neurological processes and eating disorders [15]. However, most neuroimaging studies have focused their attention on people with AN rather than BN or BED. Presumably, this is because the early neurobiological literature, which focused largely on examining structural changes associated with prolonged starvation and malnutrition in AN with Magnetic Resonance Imaging (MRI), formed a foundation for ongoing investigation in this clinical group.

The neurobiological basis of BN and BED is different to that of AN. Specifically, BN and BED are conceptualized as impulsive / compulsive eating disorders with altered reward sensitivity and food-related attentional biases [16]. Alterations in the cortico-striatal circuits of individuals with BN and BED are similar to those reported in studies of people with substance abuse, with changes in the function of the prefrontal, insular cortex, orbitofrontal cortex (OFC) and striatum [16]. In BED, individuals move from the ventral-striatal reward-based mode of reward-related food consumption, to a dorsal-striatal impulsive / compulsive mode of reward-related food consumption [16]. In BN the urge to binge eat is mediated by hyperactivity of the OFC and anterior cingulate cortex (ACC) and impaired inhibitory control from the lateral prefrontal circuits [17]. Hyperactivity of the parieto-occipital regions and hypoactivation of executive control networks in individuals with BN compared to HCs has also been reported [18].

Increased attention has been directed to the role of inhibitory control, or how well one can suppress inappropriate and unwanted actions, in BN and BED e.g. [18,19,20]. A recent meta-analysis found impaired response inhibition in BN patients when faced with eating disorder-related stimuli, alongside general impairments in inhibitory control, when compared to HCs [19]. In a recent systematic review, no definite conclusions could be drawn regarding the neurocognitive profile of individuals with BN or BED due to the diversity in methodology and small sample sizes within the majority of the studies reviewed [21]. A smaller body of research has been published over recent years examining the neurobiology of patients who binge eat e.g. [22,23,24]. The frontostriatal area, which has a central role in controlling goal-directed thoughts and behaviours including response inhibition and reward processing [25], has emerged as particularly relevant to BN [25]. Evidence suggests the diminished frontostriatal brain activation in BN patients contributes to the severity of symptoms [26]. Furthermore, individuals with BN display altered temporal choice behavior, the degree of preference for immediate rewards over delayed rewards [27].

Overall, it is clear that there is a rapidly expanding body of neurobiological research in BN and BED. Completing a rigorous review will provide a novel and warranted overview of the deficits and differences that occur in these clinical groups. This will increase our understanding of the neurological underpinnings of BN and BED, which is critical considering the extremely high rates of psychiatric comorbidities and risk of suicide in people with BN and BED [7, 28]. The pathophysiology of BN and BED is poorly understood and as a result, effective evidence-based treatments require further refinement [27]. Increased knowledge of these factors for BN and BED will better inform treatments across bulimic eating disorders.


There has been a recent shift in the treatment framework for eating disorders, to include knowledge of the structural and functional changes in the brain that take place in the ill state. Recent developments in neuroimaging have allowed some clinical and psychopathological symptoms to be linked to specific neural structures and systems. To date, the majority of this research in people with eating disorders has examined individuals with AN. The first aim of this systematic review is to contribute a comprehensive understanding of the existing neuroimaging research in individuals with BN or BED where BEs form the core eating disorder pathology, rather than a possible clinical feature. The second aim relates to the clinical utility of the DSM [1] distinction between OBEs and SBEs; specifically, whether this review identifies any neuroimaging studies that assist in elucidating this matter.


Search strategy

This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for systematic reviews [29]. The final database searches were conducted on 14 February 2017 and all relevant articles published up until this time were considered against the eligibility criteria outlined below, with no restriction on publication date to maximise results. Key search terms included: eating disorder, bulimi* (bulimia, bulimic), bing* (binge, bingeing), binge eating, MRI, fMRI, SPECT, PET, CT, neuro* (neurobiology, neuronal, neurotransmitters, neuroimaging, neuroscience). The precise search strategy developed for database searches is available on request from the authors.

The systematic review was conducted in four stages:

  1. 1.

    Developing inclusion and exclusion criteria for the database searches;

  2. 2.

    Searching selected electronic databases to identify papers meeting inclusion criteria for the review;

  3. 3.

    Study selection; and,

  4. 4.

    Appraisal and write-up of the studies that met inclusion criteria.

Selection criteria

Potential peer-reviewed, published studies were identified using four electronic databases: PubMed, PsycInfo, Medline and Web of Science. Additional manual searches were conducted through reference lists. Studies were included if they (a) were an original research paper written in English; (b) studied humans only; (c) used samples of participants with clinician-diagnosed BN or BED; (d) recruited a HC sample with no eating disorder pathology and for studies including BED participants, a healthy, non-overweight control group was recruited; and (e) reported group comparisons between clinical and HC groups. Studies where participants were from adolescent or adult samples were included to broaden the number of possible studies in the review.

Inter-rater reliability

Due to the high number of studies screened by abstract (n=186), a random subset was screened by two co-authors (ST, AB) to establish inter-rater reliability of the selection criteria. Excellent inter-rater reliability was established (ST: k = 0.769, p = 0.001), (AB: k = 0.880, p = .000).

Data extraction and quality assessment

As there is no standardised criterion for the quality assessment of neurobiological studies, a modified version of the Downs and Black [30] Quality Index, adapted by Ferro and Speechley [31], was used. The Ferro and Speechley [31] index consists of 15 items of the original 27-item scale and is scored dichotomously as 0 (no/unable to answer) or 1 (yes). The index has four subscales: reporting, external validity, internal validity, and power. However within the Ferro and Speechley [31] index, some items were not applicable to the quality assessment of neurobiological studies. For this reason, four items were removed (response rate; estimates of the random variability; were staff / places / facilities where patients were studied representative of the treatment the majority of patients receive; were outcome measures valid and reliable) to prevent the neurobiological studies receiving an artificially low rating. Lastly, five additional items relevant to neurobiological studies of eating disorder patients (controlled for age; controlled for BMI; controlled for handedness; satiety pre-testing; and menstrual status) were added by the authors of this systematic review after consulting with experts in the field i.e. Psychiatrists specialising in the treatment of eating disorders; Staff Specialist Endocrinologists specialising in inpatient medical treatment for people with severe eating disorders. This created a new modified quality assessment scale for this systematic review consisting of 16 items. Quality ratings of the articles that were included in this systematic review ranged between seven and 11 out of a maximum score of 16. The majority (n=18) of the papers scored 9 or more out of 16.

The primary author conducted this modified quality assessment on all studies that met inclusion criteria for this review. To control for bias, a second author (AB) assessed 20% of the included studies using the same quality assessment. Agreement was reached over the methodology of the quality assessment and disparate ratings were discussed in two meetings. Excellent inter-rater reliability was established; Cohen’s kappa scores across the sub-set of studies ranging from (k = 0.871, p < 0.001) to perfect agreement (k = 1.0, p < .001).

Following the protocol of McClelland and colleagues [32] of a systematic review examining neuroimaging and behavioural studies, data were extracted from the included studies and summarised in a table that was then checked by two other reviewers. The data related to participants (age, female/male ratio); eating disorder diagnoses; sample size; procedure, including any task completed during neurobiological tests; exclusions; and brief findings. Due to the breadth of methodologies of the studies that met selection criteria, a narrative synthesis was then conducted, grouped according to the type of neuroimaging test and/or method used.


Search results and selection of studies

An initial 1,003 studies were identified using the search strategy described above and 811 of these were screened by title after duplicates were removed. A total of 192 abstracts were screened and 149 studies were excluded at this point. This left 43 studies screened by full-text, with 11 studies excluded at this juncture. The final number of studies included in this review was 32. The main reasons for studies not meeting the criteria were: not including a BN or BED sample; not including a HC sample or only including an overweight control sample for BED studies; using a recovered clinical population where participants had been symptom-free for over 12 months; or, using neuropsychological measures (e.g. Stroop test) [33] but not neurobiological measures (e.g. fMRI). The diversity in the methodologies within the studies included in this systematic review precluded the completion of a meta-analysis. Figure 1 presents the PRISMA flowchart describing the inclusion and exclusion process.

Fig. 1
figure 1

PRISMA flow chart of study identification and inclusion

Study characteristics

A total of n= 32 studies met the inclusion criteria for this review. Sixteen studies on participants with BN, eleven studies on participants with AN and BN, three studies on participants with BN and BED and two studies on participants with BED were selected for review. The majority of included studies (n=21) used fMRI. Seven used MRI, with one of these studies using both MRI and Positron Emission Technology (PET). Of the remaining four studies, three utilized Single-Photon Emission Computed Tomography (SPECT) and one used PET. All but two of the included studies recruited female eating disorder patients only; one study recruited both men and women [23] and one study did not report this [34]. Sample sizes were relatively small; see below for details of sample sizes grouped according to the type of neurological test performed.

Structural differences: Summary of MRI studies

MRI produces three-dimensional, anatomical images but cannot measure metabolic rates, unlike PET or SPECT. Seven studies using MRI to investigate structural differences between BN, BED and HCs met inclusion criteria. Sample sizes of MRI studies were consistently small; BN median and range: 10 (8-21); HC: 11 (7-21); for BED there was only one study, (n=17). See Table 1 for the extracted data from these studies. Earlier studies tended to examine structural differences or

Table 1 Characteristics and key findings of included studies using MRI as the primary method

volumetric differences between certain cerebral structures compared to the overall brain using a ratio calculation. Hoffman et al. [35] published one of the first neurobiological studies of BN patients; a resting-state MRI with BN and HC participants to assess cerebral atrophy. It was found that the BN group had a significantly lower sagittal cerebral:cranial ratio however there was no difference between the two groups on the ventricle:brain ratio [35]. In a similar study, Husain et al. [36] reported the ratio of thalamus:cerebral hemisphere and midbrain:cerebral hemisphere was significantly smaller in AN participants but not in BN or HC participants. Doraiswamy et al. [37] used MRI to investigate pituitary differences in AN and BN participants compared with HC subjects; results demonstrated the overall area and height of the pituitary was significantly smaller in eating disorder participants compared to the control group. Several groups reported grey matter reduction. Hoffman et al. [38] reported a significant decrease in the inferior frontal grey matter of BN participants compared to HCs. Coutinho and colleagues [22] reported a similar finding of reduced CN volume in BN participants, after conducting a resting-state MRI with BN and HC participants.

In the only study to use MRI and PET together, Galusca and colleagues [39] investigated cerebral serotonergic activity in severe BN-Purging (BN-P) (where severe BN-P was defined as at least one binge-purge episode every day for at least six months) and HC subjects two hours after lunch. Widespread abnormal cerebral serotonergic activity characterized the BN group, however inter-individual heterogeneity was found when individual comparisons were conducted between each BN patient and the HC group. This ranged from isolated to widespread increases in the binding potential of [18F]MPPF (a serotonin specific radiogland used in PET). Binding potential is the central measure of PET [39]. Finally, Schafer and colleagues [24] conducted MRI with BN, BED and HC participants to investigate grey matter volume (GMV) abnormalities. The authors used voxel-based morphometry to analyse specific brain regions known to be involved in food and reinforcement processing (medial and lateral orbito-frontal cortex [OFC], insula, anterior cingulate cortex and ventral / dorsal striatum). The BN and BED participants had greater GMV in the medial OFC compared to HC participants. The BN group also had significantly increased ventral striatal volumes, part of the neural reward system, when compared to the BED and HC groups [24].

Functional differences: Summary of fMRI studies

fMRI provides good coverage and excellent spatial resolution, relying on the interrelationship between cerebral blood flow, energy demand and neural activity [40]. The primary fMRI neuroimaging signal most researchers examine is the blood oxygen level-dependent (BOLD) contrast signal, which provides a reliable measure of a local increase in neural activity [40]. Twenty-one studies using fMRI as the primary neurological test met inclusion criteria for this review [18, 23, 25, 26, 41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57]. Eleven studied participants with BN [18, 25, 26, 43, 45,46,47, 50, 51, 53, 58], seven examined participants with BN and AN [42, 48, 49, 54,55,56,57, 59], two examined participants with BN and BED [44, 52] and one study examined participants with BED [23].

Overall, fMRI studies had marginally higher sample sizes than for the MRI studies reported above; BN median and range: 13 (8-32); HC: 19 (12-34); BED: only three studies included BED participants hence the median could not be calculated, range (12-19). See Table 2 for data extracted from these studies. As can be seen in Table 2, there is obvious heterogeneity across the design of the included fMRI studies. For this reason, fMRI results have been grouped according to the type of stimuli used during testing (decision making and learning paradigms; food-related stimuli; body image-related stimuli).

Table 2 Characteristics and key findings of included studies using fMRI as the primary method.

Non-food decision making and learning paradigms

Six papers in this review utilized decision making or learning paradigms during fMRI. Balodis et al. [23] found obese BED patients had decreased VS activity during anticipation processing while completing a monetary incentive delay task, however during outcome processing the group demonstrated diminished prefrontal cortex (PFC) and insula activity. Using a probabilistic learning paradigm (Weather Prediction Task), sub-threshold BN patients demonstrated hyperactivity and overall processing inefficiencies in the frontostriatal system [25]. A similar finding was reported by Cyr et al [43], who used a reward-based virtual learning task, with abnormal functioning of the anterior hippocampus and frontostriatal circuits reported in BN compared to HC participants. In the same study, BN symptom severity was significantly associated with the activation of the right anterior hippocampus during reward processing. Two studies [45, 46] used the Simon Spatial Incompatibility Task to examine BOLD during fMRI. In contrast to Celone et al. [25], Marsh et al. [46] found hypoactivity in the frontostriatal circuits known to contribute to self-regulatory control, including the right inferior frontal gyrus, dorsolateral PFC and putamen, in BN compared to controls. Finally, Seitz et al. [18] reported a range of differences in the neural networks associated with alerting, reorienting and executive attention between BN and HC participants, who underwent fMRI while completing a modified Attention Network Task (ANT), as well as a range of correlations between neural activity, BN symptoms and scores on a measure of impulsivity associated with attention deficit hyperactivity disorder (ADHD).

Food-related stimuli

Six of the fMRI studies in this review used food-specific stimuli; most of these used photographs of food items [26, 42, 52, 54, 58], however one study used actual food stimulus of 0.5mL portions of chocolate milkshake [58], and one study asked participants to think about eating the food shown to them in photographs [42]. In the first study to examine neural reward circuitry in BN in response to actual and anticipated food intake [58], decreased but not significantly different activation was found in the right precentral gyrus during both anticipating and consuming chocolate milkshake, and decreased activation in the left middle frontal gyrus, right posterior insula and left thalamus, compared to the HC group. The precentral gyrus is the site of the primary motor cortex while the insula has a central role in gustatory and hedonic taste processing and alongside the middle frontal gyrus, it is activated in response to pleasurable taste [58, 60, 61]. Brooks et al [42] compared BN, AN and HC participants’ neural responses to images of high- and low-energy foods versus non-food items. In response to food images, the BN group demonstrated increased activation in the visual cortex, right dorsolateral prefrontal cortex, right insular cortex and precentral gyrus. Relative to the HC group, the BN group also showed deactivation in the bilateral superior temporal gyrus/insula and visual cortex, and compared to the AN group, had deactivation in the parietal lobe and dorsal posterior cingulate cortex and increased activation in the caudate, superior temporal gyrus, right insula and motor area [42].

The remaining studies utilizing food images reported a range of both decreased and increased neural activation in the binge eating groups compared to AN and HC participants. Schienle and colleagues [52] reported increased insula activation in women with BN in their study using images of high-calorie foods, disgust-inducing and neutral images during fMRI following an overnight fast, compared to BED and HC groups. Food images were experienced positively across all groups with increased activation of the orbitofrontal cortex, anterior cingulate cortex and insula and there were no group differences in neural response to viewing disgust-inducing images. Women with BED demonstrated greater medial orbitofrontal response while viewing food images compared to BN and HC groups, while the BN group demonstrated greater anterior cingulate cortex and insula activation [52]. In a study examining neural response to food images used as interference during the Stroop task [33] (a neuropsychological test of self-regulation utilising the frontostriatal region), women with BED had stronger activation in the VS, while women with BN had greater activation in the premotor cortex and dorsal striatum [44].

Skunde et al. [26] personalized visual food stimuli for BN participants, by asking them to select eight favourite food images to use during a measure of behavioural inhibition, finding the BN group had reduced motor cortex activation including the primary motor, premotor and primary somatosensory cortices; and reduced activation in the right sensorimotor area (postcentral and precentral gyrus) and right dorsal striatum (caudate nucleus, putamen), relative to HCs. Importantly, these results suggest diminished frontostriatal and sensorimotor control contribute to diminished inhibitory control in BN. Finally, Uher et al. [54] found women with BN had decreased activation in the anterior and lateral prefrontal cortex in response to viewing food images compared to AN and HC groups, and greater occipital and cerebellar activity compared to the HC group.

Body image-related stimuli

Body image distortion is a key symptom of eating disorders. Six studies included in the review used body image-related photographs, images or tasks during fMRI [48,49,50, 53, 55, 56]. As in the other categories of fMRI studies, there was heterogeneity in the stimuli used. One study used negative body-related words e.g. obesity [49], reporting distorted cognition of negative body image words in women with BN and AN may be linked to increased activation in the amygdala and medial prefrontal cortex (mPFC). Two of the studies used real and distorted photographs of participants’ own bodies and control bodies. Miyake, Okamoto, Onada, Kurosaki et al. [48] reported the amygdala and mPFC were significantly activated in AN and HC women in response to their own ‘fat’ distorted image however this wasn’t found in BN women. Mohr and colleagues [50] used similar stimuli and reported that BN participants did not recruit the middle frontal gyrus (MFG) compared to HCs when estimating the size of their bodies, possibly reflecting reduced spatial manipulation. Increased activity in the lateral occipital cortex was sensitive for body size distortions in the control group but not in the BN group and the authors proposed the pattern of results may underlie body size overestimation in BN [50]. Interestingly, in the BN group a linear trend was observed, wherein insula and MFG activity declined as body photographs moved from thinner to actual and fatter images [50]. In a related study, Vocks et al. [56] used standardized photos of women’s own bodies and another woman’s body wearing a bikini, finding increased activation in the left middle temporal gyrus and middle frontal gyrus in BN and AN groups. Two studies [53, 55] used non-naturalistic stimuli. Spangler et al. [53] examined the activity of the mPFC, associated with self-referencing, during fMRI while participants imagined their bodies being compared to computer-generated ‘thin’ (Body Mass Index [BMI] =18) and ‘fat’ (BMI = 31) images. Women with BN experienced significantly greater mPFC activation when viewing the overweight female image compared to HCs, while no differences were found between groups when viewing the thin female image. Lastly, Uher et al. [55] used simple line drawings of underweight (BMI = <17.5), normal weight (20 < BMI < 25) and overweight (BMI = >27.5) bodies and found no regions of significantly increased activation in women with BN or AN compared to the HCs, however reported the patient group as a whole demonstrated weaker occipitotemporal cortex and parietal cortex activation to body shapes compared to HCs.

fMRI studies – other

Three fMRI papers that did not fit into the previous categories are reviewed here. Amianto and colleagues [57] conducted one resting-state fMRI in AN and BN groups, finding grey matter reduction and decreased connectivity of the cerebellar network to the parietal cortex and increased bilateral connectivity of intrinsic connectivity networks (ICNs). The BN group, when compared to the AN and HC groups, demonstrated grey matter reduction in the caudate nucleus (CN), part of the dorsal striatum and frontostriatal circuit. Marsh and colleagues [47] assessed morphological measures of the cerebral surface and compared to HCs, the BN group had significant reductions of local volume on the brain surface in the frontal and temperoparietal areas [47]. The local volume reduction in the inferior frontal regions was inversely correlated with age, symptom severity and pre-fMRI performance on the Stroop test. Pringle et al. [51] used a self-referent emotional processing task in BN, wherein participants had to rapidly endorse 60 personality characteristic words as either ‘me’ or ‘not me’. The BN group experienced decreased activity in the parietal, occipital and limbic areas when processing negative personality descriptors compared to HCs [51].

Functional differences: Summary of SPECT and PET studies.

Three studies met inclusion criteria for this systematic review using SPECT, which provides a functional, quantitative measure of regional cerebral blood flow (rCBF), a metric of brain function [62]. Two studies in this review used PET; one was described earlier that used combined MRI and PET [39], and the other described here using only PET. PET provides a measure of glucose metabolism rates in the brain, also a measure of brain function. Sample sizes were extremely small in this category of papers, relative to MRI and fMRI studies; BN median and range: 8 (5-21); HC:11.5 (9-12); BED: only one study included participants with BED (n=8). See Table 3 for the data extracted from these studies.

Table 3 Characteristics and key findings of included studies using SPECT and PET as the primary method.

Two of the SPECT studies [34, 63] measured participants’ rCBF during viewing of disorder-related stimuli or neutral stimuli. Beato-Fernandez et al. [34] examined rCBF across AN-Restricting (AN-R), AN-Binge-Purge (AN-BP), BN-Non-Purging (BN-NP), BN-Purging (BN-P) and HCs using three SPECT imaging procedures during rest, calm visual stimulus, and after seeing their own body image photographs. In the BN-P and AN-R groups, increased rCBF in the right temporal area was found when going from neutral to body image visual stimulus (Beato-Fernandez et al., [34]). Karhunen and colleagues [63] also found increased rCBF during exposure to food images compared to neutral images, in the left frontal and prefrontal cortices in obese BED participants compared to obese non-BED and HC participants. Nozoe and colleagues [64] completed SPECT before and after AN, BN and HC women ate a slice of cake and found the BN group had the highest rCBF before eating in the left temporal and bilateral inferior frontal regions, but the lowest cortical activity after eating. Finally, Delvenne et al. [65] completed a resting-state PET with a chemical marker to assess cerebral glucose metabolism, finding women with BN demonstrated absolute glucose hypometabolism globally and regionally, most notably in the parietal and superior frontal cortices, compared to HCs.


This systematic review identified and reviewed 32 papers investigating neural differences between individuals with BN and / or BED and HC groups [18, 22,23,24,25,26, 34,35,36,37,38,39, 42,43,44,45,46,47, 49,50,51,52,53,54,55,56,57,58,59, 63,64,65]. Included in this review were sixteen studies on participants with BN, eleven studies on participants with BN and AN, three studies on participants with BN and BED and two studies on participants with BED. The objectives of this review were first, to provide a synthesis of published studies on neuroimaging in BN and BED. Due to the heterogeneity of the 32 studies, results were reviewed according to the method of the study and type of neurological test completed (MRI, fMRI, SPECT and/or PET). The evaluation of literature indicates that it is too early to make any definite conclusions about the neuroimaging profile of individuals with BN or BED. The diverse range of neuroimaging procedures and stimuli used during testing coupled with small sample sizes impeded the ability to draw many clear conclusions. Despite this, a discussion is presented below which attempts to highlight the findings in a meaningful manner.

In relation to the second objective, to identify neurobiological studies that will assist in elucidating the apparent decreasing clinical utility of OBEs and SBEs, no studies were found wherein comparisons were made between participants reporting OBEs versus SBEs. It is worth noting that a number of studies in this review compared sub-groups of participants based on severity [24, 26, 35, 39, 45, 47, 52, 58], which was exclusively defined as the frequency of symptoms, rather than an attempt to quantify the actual amount of food consumed during a BE. The frequency of BE and purging in BN is considered an important predictor of therapeutic outcome [26] and this review certainly highlights that more aberrant neurobiological activity is reported in patients with more frequent binge eating or bulimic episodes.

If it is accepted that the severity of bulimic symptoms in the context of clinical assessment and neuroimaging research is based on the frequency of binge and / or purge episodes, it raises further doubt regarding the clinical utility and validity of continuing to attempt to quantify individuals’ binges as OBEs or SBEs.

MRI studies

Seven studies included in this review reported on data obtained from MRI [22, 24, 35,36,37,38,39]. The findings of MRI studies were mixed; most identified structural changes in the brains of BN and BED patients. Of the seven studies, only one included both BN and BED participants [24]; two studies recruited BN and AN participants [36, 37]; and four investigated BN participants only [22, 35, 38, 39]. Of the two studies investigating BN and AN participants, one reported similarities in both groups in terms of smaller pituitary glands, which the authors postulated may have atrophied following prolonged malnutrition [37]. The pituitary gland is central in the hypothalamic-pituitary-gonadal axis and is critical for normal sexual and hormonal development in puberty. A recent study [66] found age, puberty stage, testosterone and estradiol levels predicts pituitary volume in adolescents, which may be relevant to this finding considering the onset of illness is usually during adolescence. The second study reported the midbrain and thalamus demonstrated significant volume reduction only in the AN group, not in the BN and HC groups [36]. The thalamus is thought of as the ‘gate keeper’ to the cerebral cortex and is centrally involved in taste and gustatory processing, before communicating sensory information to the frontal region and insula for further processing [67].

One MRI study compared BN, BED and HC groups [24], finding evidence of structural changes in the reward-learning circuit; specifically, increased grey matter volumes in the medial orbitofrontal cortex (OFC) in both BN and BED. This finding may reflect differential reward processing as the OFC is implicated in the hedonic value of food stimuli [24, 61]. fMRI studies in this systematic review have also highlighted alterations in the medial OFC associated with processing visual food reward cues in eating disorder groups compared to HCs [52, 54, 63]. Schafer and colleagues [24] also found increased volume in the VS in BN, which was significantly and positively correlated with a lower BMI and increased frequency of purging. The central role of the striatum, in particular the VS, in the processes of decision making, reward and motivation, is now well-accepted based on a large number of human neuroimaging studies [68]. This finding, in combination with increased medial OFC volume, suggests a joint alteration of food reward processing and instrumental behaviour to reduce the chance of weight gain as the end goal [24].

The four remaining MRI studies compared BN and HC groups only. Three studies [22, 35, 38] reported structural changes in terms of cortical atrophy or volume reduction in the BN group, firstly in the ratio of cerebral to cranial area [35] and in the second paper, in the inferior frontal grey matter [38]. We believe that Hoffman and colleagues [35] made the first critical finding of a significant positive correlation between illness severity (binge frequency) and structural changes in the brain. The third paper to identify structural changes found volume reduction in the caudate nucleus within the frontostriatal circuit [22]. Lastly, Galusca et al. [39] reported widespread impairment in serotonergic activity in BN patients during PET and MRI, which is consistent with well-known research that serotonergic activity is disturbed in BN, and serotonin-modulating medications decrease BN symptoms independently of their anti-depressant effects [69]. It is notable that Galusca and colleagues’ [39] study recruited only severe BN-P participants, where the frequency of binge-purge episodes had to be a minimum of at least once daily for a minimum of six months, however we consider this group to be more representative of individuals likely to seek treatment, due to the distress associated with symptoms at this level.

The collective MRI results reveal several key findings. Firstly, in BN groups structural changes have been consistently reported, firstly in the ratio of cerebral to cranial area volume [35]; decreased inferior frontal grey matter [38]; reduction within the frontostriatal circuit, specifically in the caudate nucleus [22]; and volume reduction in the pituitary gland [37]. In one study [24], increased medial OFC volumes characterised BN and BED patients while increased volumes within the VS, dorsal striatum, medial and lateral OFC was found in BN patients only, and BED patients had increased volume within the ACC. The only combined PET and MRI study included in this review highlighted widespread serotonin dysfunction in individuals with severe BN [39].

fMRI studies

Twenty-one studies in the present review used fMRI as the primary method of investigation [18, 23, 25, 26, 41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57]. Studies included in this review using fMRI techniques yielded a broad range of results. With regards to studies of food-specific stimuli, results suggested that patients with bulimic pathology have less activation in gustatory and reward regions before and during eating, which may mediate the tendency to over-consume and binge eat [58]. Schienle and colleagues [52] reported greater activation in the insula and the ACC in BN patients, which was positively associated with frequency of BEs. An interesting finding in this study was the differential response in BED patients, producing enhanced reward sensitivity and medial OFC responses compared to BN and HC groups [52]. In response to a measure of inhibitory control (a food-specific no-go task), BN participants demonstrated decreased activation in the right postcentral and precentral gyrus, and right dorsal striatum (caudate nucleus, putamen); diminished frontostriatal brain activation was associated with high symptom severity in BN [26]. This is of note as diminished frontrostriatal brain activation may contribute to symptom severity. Uher and colleagues [54] also found diminished activity, however this was in the anterior and lateral PFC of BN patients, in response to food images. The lateral PFC is associated with suppressing unwanted behaviours, hence impaired activity in this region may underlie the disinhibition of eating behavior [54, 70]. Aberrant responding in the PFC is common to eating disorders, obsessive-compulsive disorders (OCD) and addictive disorders and may underlie some of the compulsive features of these illnesses, while the OFC and ACC are areas where the convergence of processing of emotional information and are consistently implicated in OCD and affective disorders [54, 71, 72].

In response to food images used as interference for behavioural performance in the Stroop task [33], women with BED had stronger activation in the VS, while women with BN had greater activation in the premotor cortex and dorsal striatum [44]. The aberrant activity of the ventral and dorsal frontostriatal regions in response to food images may underlie increased reward sensitivity and habitual binge eating behaviours in BED and BN. In another study, BN patients had greater activation in areas associated with somatosensory and motor responses in the right insula cortex and post-central gyrus when asked to think about eating the food shown in photographs [42].

Six fMRI studies included in this review utilised body image-specific stimuli [49, 50, 53, 55, 56, 59] and results were mixed. One study [55] reported the activity of the lateral fusiform gyrus and parietal cortex were decreased in eating disorder participants [55] while in another study, in response to morphed (‘fat’) photographs of their own and another woman’s bodies, BN participants did not show significant activation of the amygdala or PFC, unlike AN and HC groups, however they did demonstrate activation in the occipital and parietal lobes [59]. This finding was partly in contrast to Mohr and colleagues [50], who found women with BN did not demonstrate a modulation in the occipital cortex while looking at distorted photographs of their own bodies, unlike HC women. Also, the BN group failed to execute the middle frontal gyrus (MFG) during a body size estimation task, while the HC group did, suggesting a reduced spatial manipulation capacity in BN participants [50]. The MFG is believed to be the gateway between top-down and bottom-up attentional processes [73]. In response to negative body image words, the BN and HC groups differed from the AN group by not demonstrating significant activation of the right amygdala, while the BN and AN-BP groups demonstrated left mPFC activation [49]. Spangler and colleagues [53] also found increased mPFC activity in BN, specifically while looking at ‘fat’ computer generated images of female bodies compared to HCs, with peak activity in the pregenual anterior cingulate cortex (pgACC), which is thought to be the affective area of the ACC, and has a key role in emotional processing and emotion regulation possibly through modulation of the amygdala [53, 74]. Also reporting differential activity in the amygdala, Vocks and colleagues [56] found women with BN and HCs had decreased amygdala activity relative to women with AN when looking at photographs of another woman wearing a bikini, however when viewing photographs of their bodies while wearing a bikini, AN and BN groups had reduced inferior parietal lobe activity. The involvement of the amygdala in processing body-related stimuli underlines the dominant emotional processing taking place in AN, while the available data suggest that in BN, processing involves more spatial perception and comparisons in size [49] with the lateral occipital cortex being a key region for the perception of the human body [75]. Involvement of the mPFC may reflect attempted emotional regulation in response to this disorder-specific stimuli [49].

A further six fMRI papers investigated the neural correlates of decision making or learning paradigms [18, 23, 25, 43, 45, 46]. Decreased bilateral VS activity during anticipatory reward and loss processing was reported in BED participants compared to obese participants (without BED), alongside diminished PFC and insula activity during outcome processing [23]. Abnormal functioning of the anterior hippocampus and frontostriatal regions were reported in adolescent girls with BN, suggesting that imbalances in neural circuits of control and reward may develop earlier in the course of the illness [43]. Two studies using spatial incompatibility tasks [45, 46] both reported hypoactivity within the frontostriatal circuits of women and female adolescents with BN, which again highlights impaired self-regulatory processing. During a measure of probabilistic category learning, women with BN demonstrated diminished activity in the areas of the brain associated with episodic memory during early learning, and late increased activity in areas associated with category learning [25]. These results indicate women with BN may have suppressed early learning, or fast and flexible learning, which may translate into short-term memory deficits. Lastly, Seitz and colleagues [18] demonstrated significantly altered neural activity in all three attentional networks (alerting, reorienting and executive attention) in women with BN.

The three remaining fMRI studies included in this review didn’t fall into any of the previous categories, hence are discussed here [47, 51, 57]. Firstly, when processing negative self-referent emotive words related to eating disorders BN patients demonstrated hypoactivation in parietal, occipital and limbic regions including the amygdala [51]. Reduced activation of the amygdala highlights deficits in emotional appraisal and processing in BN patients, while the hypoactivation of the parietal and occipital lobes indicates down-regulating of attention and visual processing respectively, hence the authors proposed the BN group may have avoided engaging in the task due to the aversive valence of the stimuli. In the only study to complete a resting-state fMRI, results showed hyperconnectivity of the cerebellar network, heavily involved in processing emotion, and the parietal cortex, as well as increased bilateral connectivity of the cerebellar intrinsic connectivity network with the temporal poles, which are thought to have a role in processing social behavior and emotional stimuli in BN and AN groups [57]. In the BN group only, increased connectivity of the cerebellar network with the ACC was reported [57]. The differential activation of the ACC in BN emerged as a common finding within other papers in this review [45, 52].

In the third study, significant volume reduction in the frontal and temperoparietal regions in adult and adolescent BN groups was reported and furthermore, an inverse correlation whereby greater reduction in inferior frontal regions was found in patients with higher symptom severity, age and Stroop interference scores [47]. Volume reduction abnormalities, specifically on the surface of the inferior frontal lobe, may reflect a global change in this region and possibly contribute to deficits of self-regulation in feeding and other behaviours seen in BN [47].

The collective fMRI findings highlight several key findings. Hypoactivity in the frontostriatal circuits was reported in four fMRI studies of BN patients in the acute illness state [26, 43, 45, 46], which may promote the impulsive and dysregulated eating and emotion-related behaviours seen in this illness. It should be noted that one study reported hyperactivity in the frontostriatal circuits [25]. We suggest that both of these profiles of activity - hypo or hyperactivity – indicate an inefficiency of this system in BN. Next, following on from Hoffman et al’s [35] early MRI finding of a significant positive correlation between the degree of cortical atrophy and illness severity / binge frequency in BN, two additional fMRI studies have also highlighted an important link between illness severity in BN and aberrant neurological activity. This includes increased insula activation [52], involved in the neurological processing of food-related stimuli [42], and diminished frontostriatal activity [26], which contributes broadly to emotion, motivation, movement processes and importantly, is thought to underlie self-regulatory control. Two studies reported diminished ‘fast and flexible’ (early) learning [25] and attentional capacity [18] in BN participants.

SPECT and PET studies

Three studies in this review used SPECT imaging; two studies investigating participants with BN and AN, and one study investigating participants with BED. All three studies found increased rCBF in response to disorder-related stimuli, in the right temporal area in BN-P [34], left frontal and PFC in BED [63] and left temporal and bilateral inferior frontal regions in BN participants [64]. Increased blood flow to the right temporal lobe has been associated with phobic responses [76] and the results of Beato-Fernandez and colleagues’ [34] were proposed as a discriminant variable, supporting the idea that the BN sub-phenotypes (BN-P and BN-NP) are significantly different in relation to neural responses and psychopathology. In obese BED patients, increased rCBF was found in the left frontal and PFC while looking at a portion of real food after fasting overnight [63]. Previous research has found obese non-BED women had increased rCBF in the opposite (right) hemisphere during food exposure [77], which is in line with previous evidence of cerebral asymmetry in eating disorders across diagnostic groups [78, 79]. Increased rCBF in the left temporal region and bilateral inferior frontal regions was reported in women with BN before eating a slice of cake, however this group had the least post-eating activity compared to AN and HC groups [64], highlighting that BN and AN groups demonstrated an opposite pattern of frontal activity to the slice of cake. Finally, one study used resting-state PET, finding global and regional glucose hypometabolism in BN participants, with significantly reduced metabolism in the parietal cortex [65]. Phillipou et al [80] reported the same finding in their systematic review of the neurobiology of AN patients, which is not surprising given the parietal cortex is implicated in body image perception [81].


The primary limitation of this systematic review is the heterogeneity of the methodologies across the included studies, with regards to the neuroimaging test performed and the stimuli or paradigms used during the tests, in combination with small sample sizes. Furthermore, these factors precluded a meta-analysis from being conducted. Although the inconsistent methodologies and small sample sizes decrease the rigour and the degree to which we can interpret these results collectively, we nonetheless believe our review will contribute to increased understanding of the neurobiological mechanisms underlying binge eating in BN and BED. Following on from Van den Eynde and colleagues [21], the findings were discussed collectively wherever possible because of the dimensional approach we also took to binge eating, however it is not clear whether BN and BED share more neurological features than not, as only three of the thirty-two studies in this review compared BN and BED groups.

Neurological performance is at least partly state-dependent, yet hunger/satiety, or the time of the last meal prior to participation were not controlled in the majority of studies. It is therefore impossible to delineate the contribution of potential caloric deprivation, which can lead to metabolic and neuroendocrine changes in the brain [25]. Given hunger may result in heightened neural reward activation in response to eating a portion of food, differences between people with and without BN or BED may be more evident after eating [58]. Furthermore, due to the known cycles of actual or attempted restriction following binge episodes, giving a snack at a prescribed time prior to testing may have leveled differences in reward activity.

Similarly, no studies in this review controlled for stage of menstrual cycle which may have affected results; there is evidence of neurofunctional modulation of the reward system by gonadal steroid hormones while ovarian steroids modulate reward-evoked neural activity in humans [82]. Completing an fMRI study, Dreher and colleagues [82] found that during the midfollicular phase (days 4-8 post-onset of menses) women anticipating uncertain rewards activate the orbitofrontal cortex and amygdala more than during the luteal phase (6-10 days after lutenising hormone surge). Also, we believe only one study controlled for stage of treatment by completing the neurological scan before, or in the first week of, cognitive therapy [64]; most did not account for this potentially confounding variable. With regards to medication, there was heterogeneity in terms of whether psychotropic medication, SSRI’s or antidepressants were an exclusion for participation. One study addressed the potential confounding factor of SSRI medication on neurological activity and performance, by completing a second analysis of their fMRI data excluding participants taking medication, finding that the two groups differed in neural activity [54].

With regards to additional participant characteristics, men were not included with the exception of one, or possibly two studies [23, 34]. Also, the majority of studies recruited clinical samples of eating disorder patients versus community-based recruitment yet particular psychiatric comorbidities were excluded in some studies, for example depression. Approximately 90% of people with BN will have a lifetime diagnosis of another psychiatric disorder [83], while for those with BED, the greatest lifetime comorbidity is for other eating disorders followed by depression and bipolar disorder [28]. It is clear that for individuals with clinical severity binge eating, psychiatric comorbidities are the rule rather than the exception, hence one must question the decision to exclude participants with psychiatric comorbidities given they are representative of the norm.

Recommendations for future research

Considering poor treatment outcomes for many individuals with BN and BED, evidence-based treatment requires critical further development and is very unlikely to come from a refinement of traditional psychological treatment, or ‘talking therapy’, alone [10]. Talking therapies target ‘top-down’ cognitive processes; however, it is apparent that developing greater insight into the neurological mechanisms of BN and BED, in particular behavioural inhibition deficits, which are the hallmark of BN and BED, will inform brain-based treatment frameworks [26]. Repetitive transcranial magnetic stimulation (rTMS), a form of neuromodulation, has been shown to decrease cue-induced food cravings for individuals with bulimic-type eating disorders [17]. A second potential treatment approach warranting further research is the use of neurofeedback in the treatment of BN or BED, which is a form of biofeedback that trains individuals to actively and voluntarily regulate their neural activity in response to real-time feedback via a brain-computer interface [84]. The value of neurofeedback is that, unlike fMRI, it provides a way of assessing neural activity and responses via its effect on behavior and as such, can be seen as ‘bridging the gap’ between traditional psychological treatment approaches and our current neurobiological knowledge of BN and BED [84]. Electroencephalography (EEG) feedback has been extensively investigated in ADHD and overall, findings suggest its use in this group translates into significant and lasting improvements in cognition and behavior that are equal to or better than medication [84, 85]. Considering the overlap between BN, obesity and ADHD [20, 86], combined with the results discussed in this review highlighting deficits of frontostriatal and attentional functioning, this suggests EEG neurofeedback certainly presents potential for the treatment of BN and BED.

While the cost of conducting neurobiological research is extremely high relative to other research, future research design utilizing larger sample sizes and power would contribute much more knowledge to this area, thereby enhancing the rigor that this area of research warrants. Additionally, with increased awareness of the need for rigorous study design and the lack of data reproducibility, especially in neuroimaging research, future studies would be well-placed to design and register pre-clinical experiments and plan carefully around how neuroimaging data is collected and analysed in advance.

This review only included studies with patients currently in the ill-state of either BN or BED, so it is not possible to speculate on whether the differences reported were a precipitant or consequence of the mental illness. It is accepted that eating disorders demonstrate considerable pathoplasticity [10]. Therefore, larger collaborative studies conducting neurobiological testing at numerous time points with the same cohort of BN and BED patients would help to elucidate this question and present more robust research design. Similar studies have been completed in AN which have provided critical information regarding the neurological changes that take place in the acute ill phase of the illness and furthermore, how the brain ‘recovers’ following refeeding [87].

In this review, a relationship between symptom severity and neural activity was established [35, 42, 52]. Additional research is required to determine whether these differences in neural activity based on clinical severity could provide a predictor of treatment response. Finally, only one [23], or possibly two [34], studies of the thirty-two papers in this review included male BN or BED patients. There is a clear need to include male patients in future neuroimaging studies of BN and BED.


This review demonstrates a relationship between symptom severity and aberrant neural activity, and deficits in self-regulatory neural processes related to decreased activity in the frontostriatal circuits in patients with BN or BED. The extent to which the structural and functional changes described in this review occur as a result of the eating disorder, or contribute to its development remain to be established.


  1. Binge episodes (BEs) in this paper refer exclusively to binge eating episodes involving the consumption of food, excluding any other substance or item in the binge episode.





Anterior cingulate cortex

AN :

Anorexia nervosa


Anorexia nervosa-binge purge type


Anorexia nervosa-restricting type


Binge episode


Binge eating disorder


Body mass index


Bulimia nervosa


Bulimia nervosa-purge type


Caudate nucleus




Dorsolateral cortex


Dorsal striatum


Functional magnetic resonance imaging


Grey matter volume


Healthy control participants


Insular cortex


Loss of control


Middle frontal gyrus


Medial prefrontal cortex


Magnetic resonance imaging


Objective binge episode


Orbitofrontal cortex


Other Specified Feeding and Eating Disorder


Positron Emission Technology


Prefrontal cortex


subjective binge episode


Standard deviation


Single-Photon Emission Computed Tomography




Ventral striatum


  1. American Psychiatric Association. Diagnostic and Satistical Manual of mental disorders. 5th ed; 2013.

  2. Organization, W.H International Statistical Classification of Diseases and Related Health Problems, 10th Revision. 2010.

    Google Scholar 

  3. Hay P, et al. Burden and health-related quality of life of eating disorders, including Avoidant/Restrictive Food Intake Disorder (ARFID), in the Australian population. Journal of Eating Disorders. 2017;5(21).

  4. Hay P, Girosi F, Mond J. Prevalence and sociodemographic correlates of DSM-5 eating disorders in the Australian population. Journal of Eating Disorders. 2015;3(19).

  5. Ulfvebrand S, et al. Psychiatric comorbidity in women and men with eating disorders: results from a large clinical database. Psychiatry Research. 2015;230:294–9.

    Article  PubMed  Google Scholar 

  6. Arcelus J, et al. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Archives of General Psychiatry. 2011;68(7):724–31.

    Article  PubMed  Google Scholar 

  7. Pisetsky E, et al. Depression and personality traits associated with emotion dysregulation: Correlates of suicide attempts in women with bulimia nervosa. European Eating Disorders Review. 2015;23:537–44.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hay P. A Systematic Review for Psychological Treatments in Eating Disorders: 2005-2012. International Journal of Eating Disorders. 2013;46(5):462–9.

    Article  PubMed  Google Scholar 

  9. Aigner M, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Eating Disorders. Journal of Biological Psychiatry. 2011;12(6):400–43.

    Article  Google Scholar 

  10. Schmidt U, Campbell IC. Treatment of eating disorders can not remain 'brainless': the case for brain-directed treatments. European Eating Disorders Review. 2013;21(6):425–7.

    Article  PubMed  Google Scholar 

  11. Peat CM, et al. Comparitive Effectiveness of Treatments for Binge-Eating Disorder: Systematic Review and Network Meta-Analysis. European Eating Disorders Review. 2017;25(5):317–28.

    Article  PubMed  Google Scholar 

  12. [NG69], N.g., Eating disorders: recognition and treatment. 2017, NICE.

  13. Mond J, et al. Health service utilisation for eating disorders: Findings from a community-based sample. International Journal of Eating Disorders. 2007;40(5):399–408.

    Article  PubMed  Google Scholar 

  14. Hart LM, et al. Unmet need for treatment in the eating disorders: a systematic review of eating disorder specific treatment seeking among community cases. Clinical Psychology Review. 2011;31(5):727–35.

    Article  PubMed  Google Scholar 

  15. Ellison ZR, Foong J. Neuroimaging in Eating Disorders. In: Hoek HW, Treasure JL, Katzman MA, editors. Neurobiology in the Treatment of Eating Disorders. West Sussex: John Wiley & Sons; 1998.

    Google Scholar 

  16. Kessler RM, et al. The neurobiological basis of binge eating disorder. Neuroscience and Biobehavioral Reviews. 2016;63:223–8.

    Article  PubMed  Google Scholar 

  17. Van den Eynde F, et al. Repetitive Transcranial Magnetic Stimulation Reduces Cue-Induced Food Craving in Bulimic Disorders. Biological Psychiatry. 2010;67:793–5.

    Article  PubMed  Google Scholar 

  18. Seitz J, et al. Attention Network Dysfunction in Bulimia Nervosa - An fMRI Study. Plos One. 2016;8.

  19. Wu M, et al. Inhibitory control in bulimic-type eating disorders: A systematic review and meta-analysis. Plos One. 2013;8(12):e83412.

  20. Waxman SE, Systematic Review A. of Impulsivity in Eating Disorders. European Eating Disorders Review. 2009;17:408–25.

    Article  PubMed  Google Scholar 

  21. Van den Eynde F, et al. Neurocognition in bulimic eating disorders: a systematic review. Acta Psychiatrica Scandinavica. 2011;124(2):120-40.

  22. Coutinho JFP, et al. Volumetric alterations in the nucleus accumbens and caudate nucleus in bulimia nervosa: A structural magnetic resonance imaging study. International Journal of Eating Disorders. 2015;48(2):206–14.

    Article  PubMed  Google Scholar 

  23. Balodis IM, et al. Monetary reward processing in obese individuals with and without binge eating disorder. Biological Psychiatry. 2013;73(9):877–86.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Schäfer A, Vaitl D, Schienle A. Regional grey matter volume abnormalities in bulimia nervosa and binge-eating disorder. Neuroimage. 2010;50(2):639–43.

    Article  PubMed  Google Scholar 

  25. Celone KA, et al. An fMRI investigation of the fronto-striatal learning system in women who exhibit eating disorder behaviors. Neuroimage. 2011;56(3):1749–57.

    Article  PubMed  Google Scholar 

  26. Skunde M, et al. Neural signature of behavioural inhibition in women with bulimia nervosa. Journal of Psychiatry and Neuroscience. 2016;41(5):E69–78.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kekic M, et al. Increased Temporal Discounting in Bulimia Nervosa. International Journal of Eating Disorders. 2016;49(12):1077–81.

    Article  PubMed  Google Scholar 

  28. Welch E, et al. Treatment-seeking patients with binge-eating disorder in the Swedish national registers: clinical course and psychiatric comorbidity. BMC Psychiatry. 2016;16(163)

  29. Moher D. Preferred Reporting Items for Systematic Reviews and Meta-Analyses. J. Clin. Epidemiol. 2009;62:1006-12.

  30. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality of both randomised and non-randomised studies in health care intervention. Journal of Epidemiology and Community Health. 1998;52:377–84.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ferro MA, Speechley KN. Depressive symptoms among mothers with epilepsy: A review of prevalence, associated factors, and impact on children. Epilepsia. 2009;50(11):2344–54.

    Article  PubMed  Google Scholar 

  32. McClelland J, et al. A systematic review of temporal discounting in eating disorders and obesity: behavioural and neuroimaging findings. Neuroscience & Biobehavioral Reviews. 2016;71:506–28.

    Article  Google Scholar 

  33. Stroop JR. Studies of interference in serial verbal reactions. Journal of Experimental Psychology: General. 1935;18(6):643–62.

    Article  Google Scholar 

  34. Beato-Fernandez L, Rodriguez-Cano T, Garcia-Vilches I. Psychopathological alterations and neuroimaging findings with discriminant value in eating behavior disorders. Actas Espanolas de Psiquiatria. 2011;39(4):203–10.

    PubMed  Google Scholar 

  35. Hoffman GW, et al. Cerebral Atrophy in Bulimia Nervosa. Biological Psychiatry. 1989;25:894–902.

    Article  PubMed  Google Scholar 

  36. Husain MM, et al. Subcortical Brain Anatomy in Anorexia and Bulimia. Biological Psychiatry. 1992;31:735–8.

    Article  PubMed  Google Scholar 

  37. Doraiswamy PM, et al. A Brain Magnetic Resonance Imaging Study of Pituitary Gland Morphology in Anorexia Nervosa and Bulimia. Biological Psychiatry. 1990;28:110–6.

    Article  PubMed  Google Scholar 

  38. Hoffman GW, et al. Brain T1 Measured by Magnetic Resonance Imaging in Bulimia. Biological Psychiatry. 1990;27:116–9.

    Article  PubMed  Google Scholar 

  39. Galusca B, et al. Wide impairment of cerebral serotoninergic activity but inter-individual heterogeneity in bulimia nervosa patients: A pilot MPPF/PET study. World Journal of Biological Psychiatry. 2014;15(8):599–608.

    Article  PubMed  Google Scholar 

  40. Logothetis NK. The Underpinnings of the BOLD Functional Magnetic Resonance Imaging Signa. The journal of Neuroscience. 2003;23(10):3963–71.

    PubMed  Google Scholar 

  41. Bohon C. Reward abnormalities among women with bulimia nervosa: A functional magnetic resonance imaging study. Dissertation Abstracts International: Section B: The Sciences and Engineering. 2011;71(9-B):5782.

    Google Scholar 

  42. Brooks SJ, et al. Differential neural responses to food images in women with bulimia versus anorexia nervosa. PLoS ONE. 2011;6(7):e22259.

  43. Cyr M. et al. Reward-Based Spatial Learning in Teens With Bulimia Nervosa. Journal of the American Academy of Chile & Adolescent Psychiatry. 2016;55(11):962-971e3.

  44. Lee JE, Namkoong K, Jung Y. Impaired prefrontal cognitive control over interference by food images in binge eating disorder and bulimia nervosa. Neuroscience Letters. 2017;9;651:95-101..

  45. Marsh R, et al. Deficient Activity in the Neural Systems That Mediate Self-regulatory Control in Bulimia Nervosa. Archives of General Psychiatry. 2009;66(1):51–63.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Marsh R, et al. An fMRI study of self-regulatory control and conflict resolution in adolescents with bulimia nervosa. American Journal of Psychiatry. 2011;168(11):1210–20.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Marsh R, et al. Anatomical characteristics of the cerebral surface in bulimia nervosa. Biological Psychiatry. 2015;77(7):616–23.

    Article  PubMed  Google Scholar 

  48. Miyake Y, et al. Brain activation during the perception of distorted body images in eating disorders. Psychiatry Research-Neuroimaging. 2010;181(3):183–92.

    Article  Google Scholar 

  49. Miyake Y, et al. Neural processing of negative word stimuli concerning body image in patients with eating disorders: an fMRI study. Neuroimage. 2010;50(3):1333–9.

    Article  PubMed  Google Scholar 

  50. Mohr HM, et al. Body image distortions in bulimia nervosa: Investigating body size overestimation and body size satisfaction by fMRI. NeuroImage. 2011;56(3):1822–31.

    Article  PubMed  Google Scholar 

  51. Pringle A, et al. Neural correlates of the processing of self-referent emotional information in bulimia nervosa. Neuropsychologia. 2011;49(12):3272–8.

    Article  PubMed  Google Scholar 

  52. Schienle A, et al. Binge-Eating Disorder: Reward Sensitivity and Brain Activation to Images of Food. Biological Psychiatry. 2009;65(8):654–61.

    Article  PubMed  Google Scholar 

  53. Spangler DL, Allen MD. An fMRI investigation of emotional processing of body shape in bulimia nervosa. International Journal of Eating Disorders. 2012;45(1):17–25.

    Article  PubMed  Google Scholar 

  54. Uher R, et al. Medial Prefrontal Cortex Activity Associated with Symptom Provocation in Eating Disorders. American Journal of Psychiatry. 2004;161(7):1238–46.

    Article  PubMed  Google Scholar 

  55. Uher R, et al. Functional Neuroanatomy of Body Shape Perception in Healthy and Eating-Disordered Women. Biological Psychiatry. 2005;25:990–7.

    Article  Google Scholar 

  56. Vocks S, et al. Neural correlates of viewing photographs of one's own body and another woman's body in anorexia and bulimia nervosa: An fMRI study. Journal of Psychiatry & Neuroscience. 2010;35(3):163–76.

    Article  Google Scholar 

  57. Amianto F, et al. Intrinsic connectivity networks within cerebellum and beyond in eating disorders. The Cerebellum. 2013;12(5):623–31.

    Article  PubMed  Google Scholar 

  58. Bohon C, Stice E. Reward abnormalities among women with full and subthreshold bulimia nervosa: A functional magnetic resonance imaging study. International Journal of Eating Disorders. 2011;44(7):585–95.

    Article  PubMed  Google Scholar 

  59. Miyake, et al. Brain activation during the perception of distorted body images in eating disorders. Psychiatry Research. Neuroimaging. 2010;181:183-92.

  60. Small DM, et al. Changes in brain activity related to eating chocolate: From pleasure to aversion. Brain. 2001;124(9):1720–33.

    Article  PubMed  Google Scholar 

  61. Kringlebach ML, Rolls ET. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Progress in Neurobiology. 2004;72(5):341–72.

    Article  Google Scholar 

  62. Raji CA, et al. Clinical utility in SPECT neuroimaging in the diagnosis and treatment of traumatic brain injury: A systematic review. Plos One. 2014;9(3):e91088.

  63. Karhunen LJ, et al. Regional cerebral blood flow during exposure to food in obese binge eating women. Psychiatry Research - Neuroimaging. 2000;99:29–42.

    Article  PubMed  Google Scholar 

  64. Nozoe SI, et al. Comparison of regional cerebral blood flow in patients with eating disorders. Brain Research Bulletin. 1995;36(3):251–5.

    Article  PubMed  Google Scholar 

  65. Delvenne V, et al. Brain hypometabolism of glucose in bulimia nervosa. International Journal of Eating Disorders. 1997;21(4):313–20.

    Article  PubMed  Google Scholar 

  66. Wong APY, et al. Estimating volumes of the pituitary gland from T1-weighted magnetic-resonance images: Effects of age, puberty, testosterone, and estradiol. NeuroImage. 2016;94:216–21.

    Article  Google Scholar 

  67. Chapman CD, et al. T. In: Encylopedia of Neuroscience. Berlin: Springer; 2009. p. 3989–4150.

    Chapter  Google Scholar 

  68. Tremblay L, Worbe Y, Hollerman JR. The Ventral Striatum: A Heterogenous Structure Involved in Reward Processing, Motivation and Decision Making. In: Dreher JC, Tremblay L, editors. Handbood of Reward and Decision Making. Burlington, MA: Accademic Press; 2009. p. 51–77.

    Chapter  Google Scholar 

  69. Kaye WH. The Neurobiology of Anorexia Nervosa and Bulimia Nervosa. Physiology and Behavior. 2008;94:121–35.

    Article  PubMed  Google Scholar 

  70. Aron AR, et al. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nature Neuroscience. 2003;6:115–6.

    Article  PubMed  Google Scholar 

  71. Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Current Opinion in Neurobiology. 2001;11(2):240–9.

    Article  PubMed  Google Scholar 

  72. Saxena S, et al. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. British Journal of Psychiatry (Supplement). 1998;173(Suppl. 35):26–37.

    Google Scholar 

  73. Japee S, et al. A role of right middle frontal gyrus in reorienting of attention: a case study. Frontiers in Systems Neuroscience. 2015;9(23).

  74. Banks SJ, et al. Amygdala-frontal connectivity during emotion regulation. Social Cognitive & Affective Neuroscience. 2007;2:303–12.

    Article  Google Scholar 

  75. Downing PE, et al. A cortical area selective for visual processing of the human body. Science. 2001;28:2470–3.

    Article  Google Scholar 

  76. Beato-Fernandez L, et al. Changes in regional cerebral blood flow after body image exposure in eating disorders. Psychiatry Research. 2009;171:149–37.

    Google Scholar 

  77. Karhunen LJ, et al. Regional cerebral blood flow during food exposure in obese and normal-weight women. Brain. 1997;120(9):1675–84.

    Article  PubMed  Google Scholar 

  78. Wu M, et al. Greater left cerebral hemispheriic metabolism in bulimia assessed by positron emission tomography. American Journal of Psychiatry. 1990;147(3):309–12.

    Article  PubMed  Google Scholar 

  79. Andreason PJ, et al. Regional cerebral glucose metabolism in bulimia nervosa. American Journal of Psychiatry. 1992;149:1506–13.

    Article  PubMed  Google Scholar 

  80. Phillipou A, Rossell SL, Castle DJ. The neurobiology of anorexia nervosa: A systematic review. Australian and New Zealand Journal of Psychiatry. 2014;48(2):128–52.

    Article  PubMed  Google Scholar 

  81. Horne RL, Van Vactor JC, Emerson S. Disturbed body image in patients with eating disorders. American Journal of Psychiatry. 1991;148:211–5.

    Article  PubMed  Google Scholar 

  82. Dreher JC, et al. Menstrual cycle phase modulates reward-related neural function in women. PNAS Proceedings of the National Academy of Sciences of the United States of America. 2007;104(7):2465–70.

    Article  Google Scholar 

  83. Hudson JI, et al. The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication. Biological Psychiatry. 2007;61:348–58.

    Article  PubMed  Google Scholar 

  84. Bartholdy S, et al. The potential of neurofeedback in the treatment of eating disorders: A review of the literature. European Eating Disorders Review. 2013;21(6):456–63.

    Article  PubMed  Google Scholar 

  85. Meisel V, et al. Neurofeedback and standard pharmacological intervention in ADHD: A randomised controlled trial with six-month follow-up. Biological Psychiatry. 2013;94:116–25.

    Article  Google Scholar 

  86. de Zwaan M, et al. Association between Obesity and Adult Attention-Deficit / Hyperactivity Disorder in a German Community-Based Sample. Obesity Facts. 2011;4:204–11.

    Article  PubMed  Google Scholar 

  87. Krieg J-C, et al. Endocrine, metabolic, and cranial computed tomographic findings in anorexia nervosa. Biological Psychiatry. 1988;23(4):377–87.

    Article  PubMed  Google Scholar 

Download references


The authors would like to thank Ms Andreea Heriseanu for proof reading sections of this manuscript.

Author information

Authors and Affiliations



BD, PH and ST drafted the search strategy and inclusion / exclusion criterion. BD completed the finalsearch of all databases and the first screen by title and abstract. ST, AB and BD completed ratings & meetings to establish inter-rater reliability of the inclusion / exclusion criterion. PH, ST, IC and JR reviewedquality index items and suggested new items appropriate for neuroimaging studies for the modified quality index. The final quality assessment was completed by BD & AB. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Phillipa Hay.

Ethics declarations

Competing interests

BD receives / has received consulting fees from Novo Nordisk Pharmaceuticals in regards to the SaxendaCare support program. ST has received honoraria from Shire, he chairs their Australian Clinical Advisory Committee for Binge Eating Disorder, has provided commissioned reports and has received research grant funding. He has also received royalties from Hogrefe and Huber, Mc Graw hill and Routledge for published work. He also receives an honorarium from Springer for Editor in Chief of Journal of Eating Disorders. AB has no competing interests. JR has received honoraria from Shire and has been a member of their Australian Clinical Advisory Committee for Binge Eating Disorder. She is in receipt of NHMRC funding for eating disorder research. IC has and does performed clinical trials of obesity treatment and prevention some of which have been funded by government, but others by the pharmaceutical industry; his current trials have been/are funded by the NHMRC (3), NovoNordisk, Pfizer, BMS, Australian Eggs and SFI. IC has given talks for NovoNordisk, Servier Laboratories, Ache and Pfizer in the last 3 years, serves on the scientific advisory board of the Sansom Institute for Health Research, University of SA, the board of Obesity Australia, and chair the Executive Management Committee of the national Bariatric Surgical Register, ans is president of the World Obesity Federation. PH receives/has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and New South Wales Institute of Psychiatry and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, Biomed Central and PlosMedicine and she has received research grants from the NHMRC and ARC. She is Deputy Chair of the National Eating Disorders Collaboration Steering Committee in Australia (2012-) and Member of the ICD-11 Working Group for Eating Disorders (2012-) and was Chair Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP (2012-2015). She has prepared a report under contract for Shire Pharmaceuticals in regards to Binge Eating Disorder (July 2017).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Donnelly, B., Touyz, S., Hay, P. et al. Neuroimaging in bulimia nervosa and binge eating disorder: a systematic review. J Eat Disord 6, 3 (2018).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: